These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

762 related items for PubMed ID: 22000497

  • 1. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.
    Giannarini G, Petralia G, Thoeny HC.
    Eur Urol; 2012 Feb; 61(2):326-40. PubMed ID: 22000497
    [Abstract] [Full Text] [Related]

  • 2. Clinical utility of diffusion-weighted magnetic resonance imaging in prostate cancer.
    Afaq A, Koh DM, Padhani A, van As N, Sohaib SA.
    BJU Int; 2011 Dec; 108(11):1716-22. PubMed ID: 21631696
    [Abstract] [Full Text] [Related]

  • 3. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
    El-Assmy A, Abou-El-Ghar ME, Refaie HF, Mosbah A, El-Diasty T.
    BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
    [Abstract] [Full Text] [Related]

  • 4. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients.
    Thoeny HC, Triantafyllou M, Birkhaeuser FD, Froehlich JM, Tshering DW, Binser T, Fleischmann A, Vermathen P, Studer UE.
    Eur Urol; 2009 Apr; 55(4):761-9. PubMed ID: 19144456
    [Abstract] [Full Text] [Related]

  • 5. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.
    Birkhäuser FD, Studer UE, Froehlich JM, Triantafyllou M, Bains LJ, Petralia G, Vermathen P, Fleischmann A, Thoeny HC.
    Eur Urol; 2013 Dec; 64(6):953-60. PubMed ID: 23916692
    [Abstract] [Full Text] [Related]

  • 6. Diffusion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: impact on radiotherapy planning.
    Dirix P, Vandecaveye V, De Keyzer F, Op de Beeck K, Poorten VV, Delaere P, Verbeken E, Hermans R, Nuyts S.
    Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):761-6. PubMed ID: 19540069
    [Abstract] [Full Text] [Related]

  • 7. Diffusion-weighted magnetic resonance imaging in patients selected for radical cystectomy: detection rate of pelvic lymph node metastases.
    Papalia R, Simone G, Grasso R, Augelli R, Faiella E, Guaglianone S, Cazzato R, Del Vescovo R, Ferriero M, Zobel B, Gallucci M.
    BJU Int; 2012 Apr 01; 109(7):1031-6. PubMed ID: 21883835
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M.
    Acta Radiol; 2008 Dec 01; 49(10):1207-13. PubMed ID: 19031184
    [Abstract] [Full Text] [Related]

  • 9. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma.
    Ren J, Huan Y, Li F, Wang H, Ge Y, Chang Y, Yin H, Sun L.
    J Magn Reson Imaging; 2009 Aug 01; 30(2):351-6. PubMed ID: 19591203
    [Abstract] [Full Text] [Related]

  • 10. DW-MRI of the urogenital tract: applications in oncology.
    Petralia G, Thoeny HC.
    Cancer Imaging; 2010 Oct 04; 10 Spec no A(1A):S112-23. PubMed ID: 20880781
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy.
    Lista F, Andrés G, Cáceres F, Ramón de Fata F, Rodríguez-Barbero JM, Angulo JC.
    Actas Urol Esp; 2013 Oct 04; 37(7):419-24. PubMed ID: 23773823
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diffusion-weighted imaging of the male pelvis.
    Koh DM, Sohaib A.
    Radiol Clin North Am; 2012 Nov 04; 50(6):1127-44. PubMed ID: 23122042
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic efficacy of diffusion-weighted MRI for pre-operative assessment of myometrial and cervical invasion and pelvic lymph node metastasis in endometrial carcinoma.
    Koplay M, Dogan NU, Erdogan H, Sivri M, Erol C, Nayman A, Karabagli P, Paksoy Y, Celik C.
    J Med Imaging Radiat Oncol; 2014 Oct 04; 58(5):538-46; quiz 648. PubMed ID: 25046775
    [Abstract] [Full Text] [Related]

  • 15. Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging.
    Thoeny HC, Froehlich JM, Triantafyllou M, Huesler J, Bains LJ, Vermathen P, Fleischmann A, Studer UE.
    Radiology; 2014 Oct 04; 273(1):125-35. PubMed ID: 24893049
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bladder cancer: evaluation of staging accuracy using dynamic MRI.
    Rajesh A, Sokhi HK, Fung R, Mulcahy KA, Bankart MJ.
    Clin Radiol; 2011 Dec 04; 66(12):1140-5. PubMed ID: 21924408
    [Abstract] [Full Text] [Related]

  • 20. Prostate cancer - the role of magnetic resonance imaging.
    Mocikova I, Babela J, Balaz V.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Jun 04; 156(2):103-7. PubMed ID: 22837130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.